 | • レポートコード：GIR-203B16077 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ブルトン型チロシンキナーゼ（BTK）阻害剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のブルトン型チロシンキナーゼ（BTK）阻害剤の市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界のブルトン型チロシンキナーゼ（BTK）阻害剤の市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 ブルトン型チロシンキナーゼ（BTK）阻害剤市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・アカラブルチニブ、ザヌブルチニブ、イブルチニブ 用途別セグメントは次のように区分されます。 ・腫瘍、自己免疫 世界のブルトン型チロシンキナーゼ（BTK）阻害剤市場の主要な市場プレーヤーは以下のとおりです。 ・AbbVie、Johnson & Johnson、Principia Biopharma、Merck、Sunesis Pharmaceuticals、BeiGene、Novartis、Sanofi、Celgene Corporation、Loxo、ArQule、Hengrui 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、ブルトン型チロシンキナーゼ（BTK）阻害剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なブルトン型チロシンキナーゼ（BTK）阻害剤メーカーの企業概要、2019年～2021年までのブルトン型チロシンキナーゼ（BTK）阻害剤の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なブルトン型チロシンキナーゼ（BTK）阻害剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別ブルトン型チロシンキナーゼ（BTK）阻害剤の販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までのブルトン型チロシンキナーゼ（BTK）阻害剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域でのブルトン型チロシンキナーゼ（BTK）阻害剤市場予測を収録しています。 ・第12、13、14章では、ブルトン型チロシンキナーゼ（BTK）阻害剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：AbbVie、Johnson & Johnson、Principia Biopharma、Merck、Sunesis Pharmaceuticals、BeiGene、Novartis、Sanofi、Celgene Corporation、Loxo、ArQule、Hengrui ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：アカラブルチニブ、ザヌブルチニブ、イブルチニブ ・用途別分析2016年-2026年：腫瘍、自己免疫 ・ブルトン型チロシンキナーゼ（BTK）阻害剤の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ブルトン型チロシンキナーゼ（BTK）阻害剤のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ブルトン型チロシンキナーゼ（BTK）阻害剤のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ブルトン型チロシンキナーゼ（BTK）阻害剤の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ブルトン型チロシンキナーゼ（BTK）阻害剤の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Bruton’s Tyrosine Kinase (BTK) Inhibitor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Bruton’s Tyrosine Kinase (BTK) Inhibitor size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Bruton’s Tyrosine Kinase (BTK) Inhibitor market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Bruton’s Tyrosine Kinase (BTK) Inhibitor market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Acalabrutinib
Zanubrutinib
Ibrutinib
Market segment by Application can be divided into
Tumor
Autoimmunity
The key market players for global Bruton’s Tyrosine Kinase (BTK) Inhibitor market are listed below:
AbbVie
Johnson & Johnson
Principia Biopharma
Merck
Sunesis Pharmaceuticals
BeiGene
Novartis
Sanofi
Celgene Corporation
Loxo
ArQule
Hengrui
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Bruton’s Tyrosine Kinase (BTK) Inhibitor product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Bruton’s Tyrosine Kinase (BTK) Inhibitor, with price, sales, revenue and global market share of Bruton’s Tyrosine Kinase (BTK) Inhibitor in 2018 and 2019.
Chapter 3, the Bruton’s Tyrosine Kinase (BTK) Inhibitor competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bruton’s Tyrosine Kinase (BTK) Inhibitor breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Bruton’s Tyrosine Kinase (BTK) Inhibitor market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Bruton’s Tyrosine Kinase (BTK) Inhibitor sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Bruton’s Tyrosine Kinase (BTK) Inhibitor Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Acalabrutinib
1.2.3 Zanubrutinib
1.2.4 Ibrutinib
1.3 Market Analysis by Application
1.3.1 Overview: Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Tumor
1.3.3 Autoimmunity
1.4 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size & Forecast
1.4.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales in Value (2016-2026))
1.4.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales in Volume (2016-2026)
1.4.3 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Price by Type (2016-2026) & (US$/Unit)
1.5 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Production Capacity Analysis
1.5.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Total Production Capacity (2016-2026)
1.5.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Drivers
1.6.2 Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Restraints
1.6.3 Bruton’s Tyrosine Kinase (BTK) Inhibitor Trends Analysis
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Bruton’s Tyrosine Kinase (BTK) Inhibitor Product and Services
2.1.4 AbbVie Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Bruton’s Tyrosine Kinase (BTK) Inhibitor Product and Services
2.2.4 Johnson & Johnson Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Principia Biopharma
2.3.1 Principia Biopharma Details
2.3.2 Principia Biopharma Major Business
2.3.3 Principia Biopharma Bruton’s Tyrosine Kinase (BTK) Inhibitor Product and Services
2.3.4 Principia Biopharma Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Bruton’s Tyrosine Kinase (BTK) Inhibitor Product and Services
2.4.4 Merck Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Sunesis Pharmaceuticals
2.5.1 Sunesis Pharmaceuticals Details
2.5.2 Sunesis Pharmaceuticals Major Business
2.5.3 Sunesis Pharmaceuticals Bruton’s Tyrosine Kinase (BTK) Inhibitor Product and Services
2.5.4 Sunesis Pharmaceuticals Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 BeiGene
2.6.1 BeiGene Details
2.6.2 BeiGene Major Business
2.6.3 BeiGene Bruton’s Tyrosine Kinase (BTK) Inhibitor Product and Services
2.6.4 BeiGene Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Bruton’s Tyrosine Kinase (BTK) Inhibitor Product and Services
2.7.4 Novartis Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Bruton’s Tyrosine Kinase (BTK) Inhibitor Product and Services
2.8.4 Sanofi Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Celgene Corporation
2.9.1 Celgene Corporation Details
2.9.2 Celgene Corporation Major Business
2.9.3 Celgene Corporation Bruton’s Tyrosine Kinase (BTK) Inhibitor Product and Services
2.9.4 Celgene Corporation Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Loxo
2.10.1 Loxo Details
2.10.2 Loxo Major Business
2.10.3 Loxo Bruton’s Tyrosine Kinase (BTK) Inhibitor Product and Services
2.10.4 Loxo Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 ArQule
2.11.1 ArQule Details
2.11.2 ArQule Major Business
2.11.3 ArQule Bruton’s Tyrosine Kinase (BTK) Inhibitor Product and Services
2.11.4 ArQule Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Hengrui
2.12.1 Hengrui Details
2.12.2 Hengrui Major Business
2.12.3 Hengrui Bruton’s Tyrosine Kinase (BTK) Inhibitor Product and Services
2.12.4 Hengrui Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Manufacturer
3.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Bruton’s Tyrosine Kinase (BTK) Inhibitor
3.4 Market Concentration Rate
3.4.1 Top 3 Bruton’s Tyrosine Kinase (BTK) Inhibitor Manufacturer Market Share
3.4.2 Top 6 Bruton’s Tyrosine Kinase (BTK) Inhibitor Manufacturer Market Share
3.5 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Bruton’s Tyrosine Kinase (BTK) Inhibitor Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size by Region
4.1.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales in Volume by Region (2016-2026)
4.1.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Region (2016-2026)
4.2 North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue (2016-2026)
4.3 Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue (2016-2026)
4.4 Asia-Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue (2016-2026)
4.5 South America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue (2016-2026)
4.6 Middle East and Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales in Volume by Type (2016-2026)
5.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Type (2016-2026)
5.3 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales in Volume by Application (2016-2026)
6.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Application (2016-2026)
6.3 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Type (2016-2026)
7.2 North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Application (2016-2026)
7.3 North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size by Country
7.3.1 North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales in Volume by Country (2016-2026)
7.3.2 North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Type (2016-2026)
8.2 Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Application (2016-2026)
8.3 Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size by Country
8.3.1 Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales in Volume by Country (2016-2026)
8.3.2 Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Type (2016-2026)
9.2 Asia-Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Application (2016-2026)
9.3 Asia-Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size by Region
9.3.1 Asia-Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Type (2016-2026)
10.2 South America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Application (2016-2026)
10.3 South America Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size by Country
10.3.1 South America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales in Volume by Country (2016-2026)
10.3.2 South America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Type (2016-2026)
11.2 Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Application (2016-2026)
11.3 Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size by Country
11.3.1 Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Bruton’s Tyrosine Kinase (BTK) Inhibitor Typical Distributors
12.3 Bruton’s Tyrosine Kinase (BTK) Inhibitor Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Type, (USD Million), 2021-2026
Table 2. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Application, (USD Million), 2021-2026
Table 3. AbbVie Basic Information, Manufacturing Base and Competitors
Table 4. AbbVie Major Business
Table 5. AbbVie Bruton’s Tyrosine Kinase (BTK) Inhibitor Product and Services
Table 6. AbbVie Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 8. Johnson & Johnson Major Business
Table 9. Johnson & Johnson Bruton’s Tyrosine Kinase (BTK) Inhibitor Product and Services
Table 10. Johnson & Johnson Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Principia Biopharma Basic Information, Manufacturing Base and Competitors
Table 12. Principia Biopharma Major Business
Table 13. Principia Biopharma Bruton’s Tyrosine Kinase (BTK) Inhibitor Product and Services
Table 14. Principia Biopharma Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Merck Basic Information, Manufacturing Base and Competitors
Table 16. Merck Major Business
Table 17. Merck Bruton’s Tyrosine Kinase (BTK) Inhibitor Product and Services
Table 18. Merck Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Sunesis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Sunesis Pharmaceuticals Major Business
Table 21. Sunesis Pharmaceuticals Bruton’s Tyrosine Kinase (BTK) Inhibitor Product and Services
Table 22. Sunesis Pharmaceuticals Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. BeiGene Basic Information, Manufacturing Base and Competitors
Table 24. BeiGene Major Business
Table 25. BeiGene Bruton’s Tyrosine Kinase (BTK) Inhibitor Product and Services
Table 26. BeiGene Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Novartis Basic Information, Manufacturing Base and Competitors
Table 28. Novartis Major Business
Table 29. Novartis Bruton’s Tyrosine Kinase (BTK) Inhibitor Product and Services
Table 30. Novartis Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Sanofi Basic Information, Manufacturing Base and Competitors
Table 32. Sanofi Major Business
Table 33. Sanofi Bruton’s Tyrosine Kinase (BTK) Inhibitor Product and Services
Table 34. Sanofi Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table 36. Celgene Corporation Major Business
Table 37. Celgene Corporation Bruton’s Tyrosine Kinase (BTK) Inhibitor Product and Services
Table 38. Celgene Corporation Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Loxo Basic Information, Manufacturing Base and Competitors
Table 40. Loxo Major Business
Table 41. Loxo Bruton’s Tyrosine Kinase (BTK) Inhibitor Product and Services
Table 42. Loxo Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. ArQule Basic Information, Manufacturing Base and Competitors
Table 44. ArQule Major Business
Table 45. ArQule Bruton’s Tyrosine Kinase (BTK) Inhibitor Product and Services
Table 46. ArQule Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Hengrui Basic Information, Manufacturing Base and Competitors
Table 48. Hengrui Major Business
Table 49. Hengrui Bruton’s Tyrosine Kinase (BTK) Inhibitor Product and Services
Table 50. Hengrui Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Manufacturer (2019-2021e) & (K Units)
Table 52. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 53. Market Position of Manufacturers in Bruton’s Tyrosine Kinase (BTK) Inhibitor, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 54. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Production Capacity by Company, (K Units): 2020 VS 2021
Table 55. Head Office and Bruton’s Tyrosine Kinase (BTK) Inhibitor Production Site of Key Manufacturer
Table 56. Bruton’s Tyrosine Kinase (BTK) Inhibitor New Entrant and Capacity Expansion Plans
Table 57. Bruton’s Tyrosine Kinase (BTK) Inhibitor Mergers & Acquisitions in the Past Five Years
Table 58. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Region (2016-2021e) & (K Units)
Table 59. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Region (2021-2026) & (K Units)
Table 60. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Region (2016-2021e) & (USD Million)
Table 61. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Region (2021-2026) & (USD Million)
Table 62. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Type (2016-2021e) & (K Units)
Table 63. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Type (2021-2026) & (K Units)
Table 64. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Type (2016-2021e) & (USD Million)
Table 65. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Type (2021-2026) & (USD Million)
Table 66. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Price by Type (2016-2021e) & (US$/Unit)
Table 67. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Price by Type (2021-2026) & (US$/Unit)
Table 68. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Application (2016-2021e) & (K Units)
Table 69. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Application (2021-2026) & (K Units)
Table 70. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Application (2016-2021e) & (USD Million)
Table 71. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Application (2021-2026) & (USD Million)
Table 72. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Price by Application (2016-2021e) & (US$/Unit)
Table 73. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Price by Application (2021-2026) & (US$/Unit)
Table 74. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2016-2021e) & (K Units)
Table 75. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2021-2026) & (K Units)
Table 76. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2016-2021e) & (USD Million)
Table 77. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2021-2026) & (USD Million)
Table 78. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Type (2016-2021e) & (K Units)
Table 79. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Type (2021-2026) & (K Units)
Table 80. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Application (2016-2021e) & (K Units)
Table 81. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Application (2021-2026) & (K Units)
Table 82. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2016-2021e) & (K Units)
Table 83. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2021-2026) & (K Units)
Table 84. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2016-2021e) & (USD Million)
Table 85. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2021-2026) & (USD Million)
Table 86. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Type (2016-2021e) & (K Units)
Table 87. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Type (2021-2026) & (K Units)
Table 88. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Application (2016-2021e) & (K Units)
Table 89. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Application (2021-2026) & (K Units)
Table 90. Asia-Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Region (2016-2021e) & (K Units)
Table 91. Asia-Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Region (2021-2026) & (K Units)
Table 92. Asia-Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Region (2016-2021e) & (USD Million)
Table 93. Asia-Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Region (2021-2026) & (USD Million)
Table 94. Asia-Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Type (2016-2021e) & (K Units)
Table 95. Asia-Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Type (2021-2026) & (K Units)
Table 96. Asia-Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Application (2016-2021e) & (K Units)
Table 97. Asia-Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Application (2021-2026) & (K Units)
Table 98. South America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2016-2021e) & (K Units)
Table 99. South America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2021-2026) & (K Units)
Table 100. South America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2016-2021e) & (USD Million)
Table 101. South America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2021-2026) & (USD Million)
Table 102. South America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Type (2016-2021e) & (K Units)
Table 103. South America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Type (2021-2026) & (K Units)
Table 104. South America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Application (2016-2021e) & (K Units)
Table 105. South America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Application (2021-2026) & (K Units)
Table 106. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2016-2021e) & (K Units)
Table 107. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2021-2026) & (K Units)
Table 108. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2016-2021e) & (USD Million)
Table 109. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2021-2026) & (USD Million)
Table 110. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Type (2016-2021e) & (K Units)
Table 111. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Type (2021-2026) & (K Units)
Table 112. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Application (2016-2021e) & (K Units)
Table 113. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Application (2021-2026) & (K Units)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Bruton’s Tyrosine Kinase (BTK) Inhibitor Typical Distributors
Table 117. Bruton’s Tyrosine Kinase (BTK) Inhibitor Typical Customers
List of Figures
Figure 1. Bruton’s Tyrosine Kinase (BTK) Inhibitor Picture
Figure 2. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Type in 2020
Figure 3. Acalabrutinib
Figure 4. Zanubrutinib
Figure 5. Ibrutinib
Figure 6. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Application in 2020
Figure 7. Tumor
Figure 8. Autoimmunity
Figure 9. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (2016-2026) & (K Units)
Figure 12. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Price by Type (2016-2026) & (US$/Unit)
Figure 13. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Production Capacity (2016-2026) & (K Units)
Figure 14. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Drivers
Figure 16. Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Restraints
Figure 17. Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Trends
Figure 18. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Manufacturer in 2020
Figure 19. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Manufacturer in 2020
Figure 20. Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 Bruton’s Tyrosine Kinase (BTK) Inhibitor Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 Bruton’s Tyrosine Kinase (BTK) Inhibitor Manufacturer (Revenue) Market Share in 2020
Figure 23. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Region (2016-2026)
Figure 24. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Region (2016-2026)
Figure 25. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue (2016-2026) & (USD Million)
Figure 26. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue (2016-2026) & (USD Million)
Figure 28. South America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue (2016-2026) & (USD Million)
Figure 30. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Type (2016-2026)
Figure 31. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Type (2016-2026)
Figure 32. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Price by Type (2016-2026) & (US$/Unit)
Figure 33. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Application (2016-2026)
Figure 34. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Application (2016-2026)
Figure 35. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Price by Application (2016-2026) & (US$/Unit)
Figure 36. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Type (2016-2026)
Figure 37. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Application (2016-2026)
Figure 38. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Country (2016-2026)
Figure 39. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Country (2016-2026)
Figure 40. United States Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Type (2016-2026)
Figure 44. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Application (2016-2026)
Figure 45. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Country (2016-2026)
Figure 46. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Country (2016-2026)
Figure 47. Germany Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Region (2016-2026)
Figure 56. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Type (2016-2026)
Figure 63. South America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Application (2016-2026)
Figure 64. South America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Country (2016-2026)
Figure 65. South America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source